Alzheimer’s Drug Discovery Foundation - ADDF

Funding Profiles

Access available for Technion staff. Please sign in to see the Agency profiles (upper left corner)

ADDF funds drug discovery research by domestic and international investigators in academia and in biotechnology companies. ADDF seeks to fill the critical translational funding gap between basic research and later stage drug development.  Funding priorities: Early identification;  Prevention of AD and cognitive decline;  Treatment of AD and cognitive aging.

Contact information:

to contact the Foundation, please call (212) 901-8000
or contact us by on-line contact form
or mail to: info@alzdiscovery.org

The fund is not a competitive fund
web site: http://www.alzdiscovery.org/